KinoPharma
Nihombashi-hamacho
About KinoPharma
They are engaged in close research and development based on joint research contracts with universities, and they aim to develop clinical drugs with few side effects by utilizing the know-how of phosphoenzyme inhibitor research. In addition, they are working on the development of therapeutic agents for intractable diseases such as viral diseases and neurodegenerative diseases, which target kinases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $14.1M
- Last round: Series Unknown (Jan 2021)
- Website: kinopharma.com
- Phone: [email protected]
Industries & Categories
Biopharma, Clinical Trials, Pharmaceutical
Canonical: https://fsome.com/organization/kinopharma-65503 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.